Recent Articles

CoQ₁₀: Should you take this popular supplement if you're on a statin?

Microplastics: A hidden health threat?

Oat vs. dairy milk: Nutrition, benefits, and downsides

What is tempeh? Benefits, nutrition, and how to use it

Healing after food poisoning

Children of centenarians may stay healthier and live longer too, study finds

Light exposure at night may raise risk for heart disease

A lumbar belt may help ease low back pain

Whole grains may improve several heart risk factors at once

Signs of pneumonia: Sometimes vague and unexpected

Adam Kibel, MD, MHCM

Editorial Advisory Board Member, Harvard Health Publishing

Adam Kibel, MD, MHCM, is the chief of urology at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, and the Elliott Carr Cutler Professor of Surgery at Harvard Medical School. He received his BA and MD from Cornell University in 1987 and 1991 respectively. He then completed his residency at the Harvard Program in Urology (Longwood) in 1997, and a fellowship in urologic oncology at Johns Hopkins in 1999. In 2022, he received a master’s in health care management from Harvard University.

His practice focuses on minimally invasive approaches to urologic cancers. He has over 400 peer-reviewed publications, and has received grant support from multiple agencies, including the National Cancer Institute, the American Urologic Association, the American College of Surgeons, and the Department of Defense. The focus of his research is on identification and treatment of patients with aggressive genitourinary cancers though neoadjuvant therapy, improved imaging, and novel biomarkers.